PANDAS stands for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. It’s a condition in which a strep infection triggers a sudden, dramatic onset of OCD, tics, or both in children. First described in 1998, PANDAS is rare, with an estimated annual incidence of about 1 in 11,765 children between the ages of 3 and 12. The average age at diagnosis is around 6 years old.
What makes PANDAS distinctive is the speed and severity of onset. A child who seemed fine days earlier can develop intense anxiety, repetitive behaviors, or involuntary movements practically overnight, often within weeks of a strep throat infection or scarlet fever.
How Strep Triggers Brain Symptoms
PANDAS is driven by a case of mistaken identity in the immune system. When the body fights off a strep infection, it produces antibodies designed to attack the bacteria. In some children, those antibodies also happen to match proteins found on brain cells, a process called molecular mimicry. The same mechanism is responsible for Sydenham chorea, a neurological complication of rheumatic fever that has been well understood for decades.
These misdirected antibodies cross into the brain and bind to receptors involved in dopamine signaling, particularly in regions that control movement, habits, and emotional regulation. The result is a flood of excess dopamine and a loss of key signaling proteins in those brain areas. This disruption is what produces the sudden behavioral and motor symptoms that define the condition.
Symptoms and What They Look Like
The hallmark of PANDAS is the abrupt appearance of obsessive-compulsive behaviors, tics, or both. Parents often describe the change as happening “overnight.” A child might suddenly develop intense fears of contamination, begin performing elaborate rituals, or start making involuntary movements or sounds they’ve never made before.
Beyond OCD and tics, children with PANDAS commonly experience:
- Severe separation anxiety, sometimes to the point where a previously independent child refuses to leave a parent’s side
- Emotional instability, including sudden mood swings, irritability, or uncontrollable crying
- Physical hyperactivity or unusual, jerky movements
- Regression in handwriting, math skills, or other abilities
- Sleep disturbances, including new-onset bedwetting in children who had been dry at night
These symptoms tend to be episodic. They may improve or even disappear for a stretch, then return and intensify, often following another infection.
How PANDAS Is Diagnosed
There is no single blood test that confirms PANDAS. Diagnosis is clinical, meaning it’s based on a specific pattern of criteria rather than a lab result. The National Institute of Mental Health lists six key features providers look for:
- Presence of OCD, a tic disorder, or both
- Symptoms that begin between age 3 and puberty
- Sudden onset or sudden worsening of symptoms
- A confirmed strep infection (positive throat culture or history of scarlet fever) within three months of symptom onset
- Episodic severity, with symptoms that wax and wane
- Physical hyperactivity or unusual involuntary movements
All six criteria generally need to be present. The strep connection is essential. If a child develops the same sudden-onset neuropsychiatric symptoms but without evidence of strep, the broader diagnosis of PANS (Pediatric Acute-Onset Neuropsychiatric Syndrome) is used instead. PANS covers the same presentation but allows for other infectious or environmental triggers.
The Cunningham Panel Controversy
A commercially available blood test called the Cunningham Panel measures certain antibodies and immune markers associated with PANDAS. However, its reliability is disputed. A study published in Translational Psychiatry found that healthy children without PANDAS sometimes scored higher on key markers than children with confirmed cases. One patient tested three separate times and received both positive and negative results. The panel’s threshold for a positive result was established using a small sample, and the antibody levels of healthy children fully overlapped with those of children who had PANDAS. None of the panel’s markers reliably predicted how well a child would respond to treatment. For these reasons, most clinicians do not rely on it as a standalone diagnostic tool.
Treatment Approaches
Treating PANDAS typically involves two tracks: addressing the underlying infection and managing the neuropsychiatric symptoms.
When a child has an active strep infection, antibiotics are the first line of treatment. Clearing the infection removes the trigger that’s driving the immune response. In a randomized controlled trial, preventive antibiotic therapy with penicillin or azithromycin reduced both the frequency of strep infections and the severity of neuropsychiatric flare-ups in children with PANDAS. Some providers recommend a course of prophylactic antibiotics to prevent future strep infections from retriggering symptoms, similar to how children with rheumatic fever receive long-term antibiotic prevention.
For the OCD and anxiety symptoms themselves, many children benefit from cognitive behavioral therapy, particularly a form called exposure and response prevention. This approach helps children gradually face their fears and resist compulsive behaviors, and it works whether the OCD is triggered by PANDAS or develops on its own.
In severe cases where antibiotics and behavioral therapy aren’t enough, some providers turn to immune-based treatments. Plasma exchange (plasmapheresis) filters the problematic antibodies out of the blood and has shown effectiveness in severely ill patients. Intravenous immunoglobulin (IVIG) works by modulating the immune response more broadly. Both are reserved for cases where symptoms are debilitating and haven’t responded to other treatments.
Long-Term Outlook
The prognosis for most children with PANDAS is encouraging, though the path isn’t always straightforward. In a follow-up study tracking children over two to five years, the majority showed significant improvement over time. An earlier study found that only about 12% of children experienced clinically significant OCD symptoms at long-term follow-up, suggesting most children eventually recover or improve substantially.
That said, flare-ups are common during the recovery period. In the same follow-up cohort, 72% of children experienced at least one symptom exacerbation during the study period. Most children followed a relapsing-remitting pattern, where symptoms would flare, improve, and flare again before eventually settling. Only 2 out of 34 children in the study were classified as fully remitted at follow-up, while 20 followed the relapsing-remitting course. A smaller but notable group of about 9% developed a more chronic, progressive pattern requiring additional treatment.
The key factor that seems to matter most is preventing future strep infections. Each new infection can retrigger the immune response and cause another flare. Children who avoid reinfection, whether through vigilant treatment of strep exposures or prophylactic antibiotics, tend to have fewer and less severe episodes over time. For many families, the condition gradually fades as children reach adolescence and their immune systems mature.